Common Contracts

EX-2.1 2 a14-4838_1ex2d1.htm EX-2.1

Stock Purchase Agreement • May 5th, 2020 • Delaware

• Contract Type
  Stock Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

This Stock Purchase Agreement (the “Purchase Agreement”) contains representations and warranties that CardioNet, LLC, the Mednet entities and the Seller made to each other. These representations and warranties were made only for the purposes of the Purchase Agreement and solely for the benefit of the parties as of specific dates, may be subject to important limitations and qualifications agreed to by the parties and included in confidential disclosure schedules provided by the Seller to CardioNet in connection with the signing of the Purchase Agreement, and may not be complete. Furthermore, these representations and warranties may have been made for the purposes of allocating contractual risk between the parties instead of establishing these matters as facts, and may or may not have been accurate as of any specific date and do not purport to be accurate as of the date of the filing of the Purchase Agreement by the Company with the Securities and Exchange Commission. Accordingly, you sh

STOCK PURCHASE AGREEMENT by and among CARDIONET, LLC, MEDNET HEALTHCARE TECHNOLOGIES, INC., HEARTCARE CORPORATION OF AMERICA, INC., UNIVERSAL MEDICAL, INC., UNIVERSAL MEDICAL LABORATORY, INC. and FRANK MOVIZZO Dated January 31, 2014

Stock Purchase Agreement • February 3rd, 2014 • BioTelemetry, Inc. • Surgical & medical instruments & apparatus • Delaware

• Contract Type
  Stock Purchase Agreement
• Filed
  February 3rd, 2014
• Company
  BioTelemetry, Inc.
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  Delaware

This STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of January 31, 2014, by and among CardioNet, LLC, a Delaware limited liability company (“Purchaser”), Mednet Healthcare Technologies, Inc., a New Jersey corporation (the “Mednet”), Heartcare Corporation of America, Inc., a New Jersey corporation (“HCA”), Universal Medical, Inc., a New Jersey corporation (“Universal Medical”), Universal Medical Laboratory, Inc., a New Jersey corporation (“Universal Laboratory,” and together with Mednet, HCA and Universal Medical, each a “Company” and together the “Companies”), and Frank Movizzo, an individual and the sole shareholder of the Companies, (the “Seller”). Purchaser, the Companies and the Seller are sometimes referred to individually as a “Party” and collectively as the “Parties.” Certain capitalized terms which are used herein are defined in Article 1.